Navigation Links
NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
Date:11/13/2008

ANN ARBOR, Mich., Nov. 13 /PRNewswire/ -- NanoBio Corporation announced today that it will present new data in four presentations that detail milestones in its clinical and preclinical development programs in onychomycosis, acne, herpes labialis and genital herpes during the American Association of Pharmaceutical Scientists (AAPS) meeting November 16-20, 2008 in Atlanta, GA.

The company's presentation schedule during the conference:

Tuesday, November 18, 1:00 PM - 5:00 PM

-- In-vitro Skin Permeation of Novel Antimicrobial Nanoemulsion

Formulations

-- Lateral Diffusion of a Novel Antifungal Nanoemulsion In-vitro Human

Cadaver Skin

-- Pharmacokinetics of a Novel Topical Antimicrobial Nanoemulsion

Wednesday, November 19, 1:00 - 5:00 PM

-- Long Term Stability of NB-001: A Novel Antiviral Nanoemulsion

These studies confirm the skin permeation, overall safety and long-term stability of nanoemulsion-based therapies. The data support the continued development of NanoBio treatments for a wide range of skin and mucosal infections, including NanoBio's lead products identified above as well as treatments for tinea capitis (ringworm), molluscum contagiosum (pox virus warts) and other topical fungal, bacterial and viral infections.

About NanoBio

NanoBio(R) Corp. is a privately held biopharmaceutical company focused on developing and commercializing anti-infective products and mucosal vaccines derived from its patented NanoStat(TM) technology platform. The company's lead product candidates are treatments for herpes labialis (cold sores), onychomycosis (nail fungus), acne, and a broad platform of mucosal vaccines. NanoBio has demonstrated robust efficacy and safety in randomized, double-blind, placebo-controlled phase 2a and phase 2b studies involving over 800 subjects with recurrent herpes labialis. A large phase 2 trial is nearing completion in onychomycosis and clinical trials are planned for acne and an influenza mucosal vaccine in 2009. The company's headquarters and laboratory facilities are located in Ann Arbor, Mich.


'/>"/>
SOURCE NanoBio Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. NanoBio Expands Drug Development Team for Its Anti-Infective Products
2. Dr. Joyce Sutcliffe Joins the NanoBio Team as Vice President of Research
3. David M. Stout Joins NanoBio Corporations Board of Directors
4. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
5. Daniel B. Dubin, M.D., Joins NanoBio Corp.s Board of Directors
6. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
7. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
8. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
9. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
10. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
11. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... October 11, 2017 , ... A new study ... in frozen and fresh in vitro fertilization (IVF) transfer cycles. The ... IVF success. , After comparing the results from the fresh and frozen transfer ...
(Date:10/10/2017)... Poway, California (PRWEB) , ... October 10, 2017 , ... ... afternoon speaking at his local San Diego Rotary Club. The event ... San Diego, CA and had 300+ attendees. Dr. Harman, DVM, MPVM was joined ...
(Date:10/9/2017)... Oct. 9, 2017  BioTech Holdings announced today ... which its ProCell stem cell therapy prevents limb ... The Company, demonstrated that treatment with ProCell resulted ... saved as compared to standard bone marrow stem ... resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:5/23/2017)... 23, 2017  Hunova, the first robotic gym for the rehabilitation and ... launched in Genoa, Italy . The first 30 robots ... the USA . The technology was developed and patented ... the IIT spin-off Movendo Technology thanks to a 10 million euro investment ... please click: ...
(Date:4/19/2017)... , April 19, 2017 ... its vendor landscape is marked by the presence of ... is however held by five major players - 3M ... these companies accounted for nearly 61% of the global ... leading companies in the global military biometrics market boast ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, a ... authentication solutions, today announced that it has been ... Research Projects Activity (IARPA) to develop next-generation Presentation ... "Innovation has been a driving force ... program will allow us to innovate and develop ...
Breaking Biology News(10 mins):